Operator Greetings, and welcome to Ark Restaurants Fourth Quarter and Year-End 2025 Results Call. [Operator Instructions]. As a reminder, this conference is being recorded....
This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his Applied Science...
A company of Manulife Investment Management, John Hancock Investment Management serves investors through a unique multimanager approach, complementing our extensive in-house capabilities with an...
Macroeconomic volatility intensifies as interest rate hikes persist. Recession fears are evident as the aggregate demand remains relatively weaker. With that, the banking industry...
Investors often find that companies with a history of increasing dividends perform better than those without. When a company’s management announces a dividend increase,...
Medtronic (NYSE:MDT) reported its Q4 fiscal year 2023 earnings on Thursday. The numbers looked strong at first glance, with both earnings and revenues topping...
Introduction As an investor in dividend growth companies, I always seek new investment opportunities in income-producing assets. I usually add to my existing positions...
Roche Holding AG (OTCQX:RHHBY, OTCPK:RHHVF, OTCQX:RHHBF) is a good long-term biotech to own. That’s because it already has received FDA approval for its multiple...